240-566-3300

Urothelial

Study Name: FUJIFILM(FF10832-PEM-201)

Cancer Stage: IV
Key Inclusion: Progressive disease during/within 12 weeks of treatment with PD-(L)1 inhibitor
Description: A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer
Study Number: FF-10832
NCT#: NCT05318573

For more information, call 240-566-4100

All Locations

Frederick Health Rose Hill | Chest Surgery Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
301-694-5861
More Information
Frederick Health Rose Hill | Urology Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
301-663-4774
More Information
James M Stockman Cancer Institute Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-215-6310
More Information
James M Stockman Cancer Institute | Infusion Therapy Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
301-694-5580
More Information
James M Stockman Cancer Institute | Integrative Services Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-566-4100
More Information
James M Stockman Cancer Institute | Oncology & Hematology Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-566-4100
More Information
James M Stockman Cancer Institute | Radiation Medicine Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-566-4500
More Information

/

View All